HS 4160 Critical Scientific Analysis

Slides:



Advertisements
Similar presentations
Applications of Molecular Cytogenetics
Advertisements

Imatinib Resistance Geoffrey L. Uy, M.D. Associate Professor of Medicine Division of Oncology.
I’ve just been diagnosed with CML. Could you answer my questions?
Fluorescence in situ Hybridization
NYU SCHOOL OF MEDICINE CYTOGENETICS LECTURE 2
The Lightcycler. Carousel with capacity for 32 samples.
Oncogenes and Chromosomal Aberrations The Story of Abl and the Philadelphia Chromosome.
Applications of Molecular Cytogenetics Dr Mohammed Alqahtani CSLT(CG), CLSp(CG), RT,MBA, Ph.D Genomic Medicine Unit Founder & Director Center of Excellence.
Products of haematopoiesis. Leukaemia, the current hypothesis Defect in maturation of white blood cells-may involve a block in differentiation and/or.
Normal haemopoiesis. ABNORMALITIES IN THE HEMOPOIETIC SYSTEM CAN LEAD TO HEMOGLOBINOPATHIES HEMOPHILIA DEFECTS IN HEMOSTASIS/THROMBOSIS HEMATOLOGICAL.
Brent Hoffman. HOXA9 is one of the HOX transcription factors regulating Anterior to Posterior patterning in early development.
Case Study MICR Hematology Spring, 2011 Case # 5 Hee Jin Kim, Hooman Nikizad and Arthur Omuro.
Current use of imatinib in the treatment of chronic myeloid leukaemia Michael O’Dwyer Haematologica March 2003.
MOLECULAR GENETICS and LEUKEMIA Clive S. Zent M.D. Division of Hematology/Oncology.
Dr Nauman Butt – Royal Liverpool University Hospital CML Patient Seminar - 14 th November 2015 What is CML? How do we treat it? Get up to speed…
Heterogeneous group of hematopoietic neoplasms Uncontrolled proliferation and decreased apoptotic activity with variable degrees of differentiation Composed.
B-ALL as the Initial Presentation of a Hematopoietic Neoplasm with t(8;22)/BCR-FGFR1 The University of Texas MD Anderson Cancer Center Department of Hematopathology.
Case 297 Guilin Tang and Sa A. Wang Department of Hematopathology UT MD Anderson Cancer Center.
A partial nontandem duplication of the MLL gene in four patients with acute myeloid leukemia  Iveta Šárová, Jana Březinová, Zuzana Zemanová, Libuše Lizcová,
Monitoring of minimal residual disease in acute myeloid leukemia
Chronic Leukaemias Heterogeneous group of hematopoietic neoplasms
Clinically useful prognostic factors in acute myeloid leukemia
Chronic Leukaemias Heterogeneous group of hematopoietic neoplasms
Standard and variant Philadelphia translocation in a CML patient with different sensitivity to imatinib therapy  Stefania Aliano, Gabriella Cirmena, Giuseppina.
Detection of TMPRSS2-ETS Fusions by a Multiprobe Fluorescence in Situ Hybridization Assay for the Early Diagnosis of Prostate Cancer  Qi-Peng Sun, Liao-Yuan.
HS 4160 Critical Scientific Analysis
HS 4160 Critical Scientific Analysis
Droplet Digital PCR for Absolute Quantification of EML4-ALK Gene Rearrangement in Lung Adenocarcinoma  Qiushi Wang, Xin Yang, Yong He, Qiang Ma, Li Lin,
Volume 52, Issue 1, Pages (July 2007)
Flow cytometric immunophenotyping for hematologic neoplasms
Leukemia Human Disease Asma Siddique BIOT 412.
Detection of TMPRSS2-ETS Fusions by a Multiprobe Fluorescence in Situ Hybridization Assay for the Early Diagnosis of Prostate Cancer  Qi-Peng Sun, Liao-Yuan.
by Michele Paessler, and John Choi
Monitoring and Prevention of Relapse after Allogeneic Hematopoietic Cell Transplantation for Myeloid Malignancies  Ulrike Bacher, Julie-An Talano, Michael.
Cyclin D1-negative mantle cell lymphoma with cryptic t(12;14)(p13;q32) and cyclin D2 overexpression by Christian Herens, Frédéric Lambert, Leticia Quintanilla-Martinez,
A Case of FIP1L1-PDGFRA-Positive Chronic Eosinophilic Leukemia with a Rare FIP1L1 Breakpoint  Frédéric Lambert, Pierre Heimann, Christian Herens, Alain.
Figure S1. AML550 and AML719 arrays
Best Practices in Chronic Myeloid Leukemia by Multidisciplinary Teams
A leukemic stem cell with intrinsic drug efflux capacity in acute myeloid leukemia by Gerald G. Wulf, Rui-Yu Wang, Ingrid Kuehnle, Douglas Weidner, Frank.
Ayalew Tefferi, M.D.  Mayo Clinic Proceedings 
Diagnostic Hematology
HS 4160 Critical Scientific Analysis
Detection of Trisomy 12 and Rb-Deletion in CD34+ Cells of Patients With B-Cell Chronic Lymphocytic Leukemia by B. Gahn, C. Schäfer, J. Neef, C. Troff,
Relative increase in leukemia-specific DNA in peripheral blood plasma from patients with acute myeloid leukemia and myelodysplasia by Anna Rogers, Youngson.
Detection of Genetic Alterations by ImmunoFISH Analysis of Whole Cells Extracted from Routine Biopsy Material  Göran Mattsson, Soo Yong Tan, David J.P.
Fluorescence in Situ Hybridization Analysis of Immunoglobulin Heavy Chain Translocations in Plasma Cell Myeloma Using Intact Paraffin Sections and Simultaneous.
Grövdal M et al. Blood 2008;112:Abstract 223.
by John Anastasi, Rizwan Moinuddin, and Christopher Daugherty
Comprehensive Hybrid Capture–Based Next-Generation Sequencing Identifies a Double ALK Gene Fusion in a Patient Previously Identified to Be False-Negative.
Volume 14, Issue 6, Pages (December 2008)
Case study A 36-year-old woman presented with a two-month history of increasing fatigue and abdominal fullness with accompanying loss of appetite. There.
Molecular Monitoring of Chronic Myelogenous Leukemia
Daynna J. Wolff, Adam Bagg, Linda D. Cooley, Gordon W. Dewald, Betsy A
Successful Application of a Direct Detection Slide-Based Sequential Phenotype/Genotype Assay Using Archived Bone Marrow Smears and Paraffin Embedded.
Emerging Importance of Mutational Analysis in Myelodysplastic Syndrome and Acute Myelogenous Leukemia  Aaron T. Gerds, Matthew J. Walter, Bart L. Scott 
BCR-ABL1 gene rearrangement as a subclonal change in ETV6-RUNX1–positive B-cell acute lymphoblastic leukemia by Karen A. Dun, Rob Vanhaeften, Tracey J.
Leber B et al. Proc ASH 2013;Abstract 94.
Linkage, crossing over and chromosomal mapping (2).
CHRONIC LEUKEMIA BY: DR. FATMA AL-QAHTANI CONSULTANT HAEMATOLOGIST
Fluorescence In Situ Hybridization Identifies Cryptic t(16;16)(p13;q22) Masked By del(16)(q22) in a Case of AML-M4 Eo  Shakil H. Merchant, Skip Haines,
Introduction & haematological malignancies
Chronic Myeloid Leukemia: MD-2025 Chisinau, Republic of Moldova
ABT-199 efficiently kills primary AML myeloblasts as a single agent.
Clinical Lymphoma, Myeloma and Leukemia
Leukemic blasts express a “hypoxia signature
Mary Eapen  Biology of Blood and Marrow Transplantation 
by Monika Brüggemann, and Michaela Kotrova
Fig. 5 Proportions of EpCAM+ systemic tumor cells correlate with the clinical outcome of patients with MBC. Proportions of EpCAM+ systemic tumor cells.
ALK Gene Rearrangements: A New Therapeutic Target in a Molecularly Defined Subset of Non-small Cell Lung Cancer  Benjamin Solomon, MBBS, PhD, Marileila.
Presentation transcript:

HS 4160 Critical Scientific Analysis Week 4: Utility of peripheral blood dual color, double fusion fluorescent in situ hybridization for BCR/ABL fusion to assess cytogenetic remission status in chronic myeloid leukemia HS 4160 Critical Scientific Analysis

According to the authors, D-FISH stands for: De-stained FISH Dual color FISH Dual color, double fusion FISH Tri color, double fusion FISH

One limitation of D-FISH is failure to detect cryptic translocation True False

D-FISH could Significantly increase false positive events Significantly decrease false negative events Significantly decrease sensitivity Significantly decrease specificity

The only exclusion criteria the authors used was: Prior history of other cancers Prior history of AML Prior history of any CML-directed therapy Prior history of conventional cytogenetic testing

Which of the following correctly describe the probe set used? ABL gene labelled with green BCR gene on 9q34 This is a home-made probe set Fusion indicates ABL/BCR translocation

Which software program the authors used for their statistical analysis? SPSS SAS Excel GraphPad

From table I, which triplicate collection showed best correlation?

The outlier from Figure 1 had: no BCR/ABL fusion in bone marrow but with t(9;22) by CC no t(9;22) by CC but high rate of BCR/ABL fusion in bone marrow no t(9;22) by CC but high rate of BCR/ABL fusion in blood no BCR/ABL fusion in blood but with t(9;22) by CC

From table II, which pair has more samples? Bone marrow D-FISH vs. CC Peripheral blood D-FISH vs. CC Peripheral blood D-FISH vs. Bone marrow D-FISH